The Top 20 Most Undervalued Healthcare Stocks By Target Price

By
A A A

Compiled by Luis Gonzalez: The following is a list of the most undervalued healthcare stocks, when comparing the current price against the average analyst target price (used as a proxy for fair value).

Yes, this is a crude way to find undervalued companies, but the goal here is to give you a starting point for your own analysis. Full details below.

All data sourced from Finviz.


Analyze These Ideas (Tools Will Open In A New Window)

1. Access a thorough description of all companies mentioned
2. Compare analyst ratings for all stocks mentioned below
3. Visualize monthly and annual returns for all stocks mentioned

 

 

The list has been sorted by the average discount to target price.

1. Inspire Pharmaceuticals, Inc. (ISPH): Drug Manufacturers Industry. Market cap of $335.5M.  Price at time of writing $4.12 vs. target price of $6.75 (discount of 38.96%). Short float at 4.05%, which implies a short ratio of 2.59 days. The stock has lost -40.44% over the last year.

2. Corcept Therapeutics Inc. (CORT): Biotechnology Industry. Market cap of $315.58M.  Price at time of writing $4.35 vs. target price of $6.58 (discount of 33.89%). Short float at 2.84%, which implies a short ratio of 4.97 days. The stock has gained 45.33% over the last year.

3. Halozyme Therapeutics, Inc. (HALO): Biotechnology Industry. Market cap of $767.29M.  Price at time of writing $7.49 vs. target price of $11.29 (discount of 33.66%). Short float at 4.19%, which implies a short ratio of 8.15 days. The stock has gained 29.05% over the last year.

4. PROLOR Biotech, Inc. (PBTH): Biotechnology Industry. Market cap of $331.5M.  Price at time of writing $6.18 vs. target price of $8.5 (discount of 27.29%). Short float at 2.33%, which implies a short ratio of 8.48 days. The stock has gained 159.58% over the last year.

5. Thoratec Corp. (THOR): Medical Instruments & Supplies Industry. Market cap of $1.66B.  Price at time of writing $28.35 vs. target price of $38.41 (discount of 26.19%). Short float at 9.46%, which implies a short ratio of 3.69 days. The stock has gained 1.25% over the last year.

6.Human Genome Sciences Inc. (HGSI): Biotechnology Industry. Market cap of $5.07B.  Price at time of writing $26.70 vs. target price of $35.17 (discount of 24.08%). Short float at 8.11%, which implies a short ratio of 4.07 days. The stock has lost -10.85% over the last year.

7. Incyte Corporation (INCY): Biotechnology Industry. Market cap of $1.97B.  Price at time of writing $16.06 vs. target price of $21.08 (discount of 23.81%). Short float at 12.87%, which implies a short ratio of 8.59 days. The stock has gained 57.09% over the last year.

8. Optimer Pharmaceuticals, Inc. (OPTR): Biotechnology Industry. Market cap of $452.94M.  Price at time of writing $11.79 vs. target price of $15.33 (discount of 23.09%). Short float at 6.38%, which implies a short ratio of 12.61 days. The stock has lost -11.73% over the last year.

9. Abbott Laboratories (ABT): Drug Manufacturers Industry. Market cap of $73.23B.  Price at time of writing $46.96 vs. target price of $59.73 (discount of 21.38%). Short float at 0.55%, which implies a short ratio of 1 days. The stock has lost -11.36% over the last year.

10. American Medical Systems Holdings Inc. (AMMD): Medical Appliances & Equipment Industry. Market cap of $1.48B.  Price at time of writing $19.09 vs. target price of $24.1 (discount of 20.79%). Short float at 8.6%, which implies a short ratio of 7.52 days. The stock has lost -4.01% over the last year.

11. Eurand N.V. (EURX): Biotechnology Industry. Market cap of $570.M.  Price at time of writing $11.89 vs. target price of $15.0 (discount of 20.73%). Short float at 3.78%, which implies a short ratio of 1.74 days. The stock has lost -1.9% over the last year.

12. Healthways Inc. (HWAY): Specialized Health Services Industry. Market cap of $379.47M.  Price at time of writing $10.90 vs. target price of $13.69 (discount of 20.38%). Short float at 4.62%, which implies a short ratio of 6.24 days. The stock has lost -38.42% over the last year.

13. BioMimetic Therapeutics Inc. (BMTI): Medical Instruments & Supplies Industry. Market cap of $400.89M.  Price at time of writing $14.06 vs. target price of $17.63 (discount of 20.25%). Short float at 9.07%, which implies a short ratio of 17.24 days. The stock has gained 16.68% over the last year.

14. Orthofix International NV (OFIX): Medical Appliances & Equipment Industry. Market cap of $555.84M.  Price at time of writing $31.20 vs. target price of $39.0 (discount of 20.%). Short float at 5.17%, which implies a short ratio of 6.27 days. The stock has lost -4.91% over the last year.

15. Acorda Therapeutics, Inc. (ACOR): Biotechnology Industry. Market cap of $1.07B.  Price at time of writing $26.90 vs. target price of $33.58 (discount of 19.89%). Short float at 16.96%, which implies a short ratio of 8.48 days. The stock has gained 5.74% over the last year.

16. Cephalon Inc. (CEPH): Biotechnology Industry. Market cap of $4.51B.  Price at time of writing $59.59 vs. target price of $74.21 (discount of 19.7%). Short float at 14.75%, which implies a short ratio of 9.58 days. The stock has lost -6.55% over the last year.

17. China Medical Technologies Inc. (CMED): Medical Instruments & Supplies Industry. Market cap of $388.53M.  Price at time of writing $12.11 vs. target price of $15.04 (discount of 19.48%). Short float at 21.47%, which implies a short ratio of 17.39 days. The stock has lost -20.53% over the last year.

18. Warner Chilcott plc (WCRX): Drug Manufacturers - Other Industry. Market cap of $6.04B.  Price at time of writing $23.83 vs. target price of $29.42 (discount of 19.%). Short float at 1.24%, which implies a short ratio of 1.26 days. The stock has gained 18.17% over the last year.

19. Mindray Medical International Limited (MR): Medical Instruments & Supplies Industry. Market cap of $2.74B.  Price at time of writing $26.44 vs. target price of $32.46 (discount of 18.55%). Short float at 20.62%, which implies a short ratio of 20.32 days. The stock has lost -31.98% over the last year.

20. NPS Pharmaceuticals, Inc. (NPSP): Biotechnology Industry. Market cap of $550.16M.  Price at time of writing $8.20 vs. target price of $10.06 (discount of 18.49%). Short float at 3.92%, which implies a short ratio of 5.94 days. The stock has gained 140.35% over the last year.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: Investing , Investing Ideas , Stocks


Kapitall

Kapitall

More from Kapitall:

Related Videos

Stocks

Referenced

Most Active by Volume

82,059,748
  • $17.02 ▲ 0.77%
42,923,086
  • $6.01 ▼ 5.65%
41,207,616
  • $125.425 ▲ 0.72%
38,606,059
  • $2.19 ▼ 12.75%
36,042,768
  • $5.89 ▼ 3.76%
32,501,005
  • $18.84 ▲ 0.59%
32,223,916
  • $26.57 ▼ 0.26%
31,949,229
  • $33.53 ▼ 0.18%
As of 6/30/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com